Back to mobile site

NWBO Financial Facts

Research and development: 21.09M
Net loss: -29.23M
See Full Income Statement

Total liabilities and stockholders' equity (deficit): 48.94M
Total stockholders' equity (deficit): -5.02M
See Full Balance Sheet

Northwest Biotherapeutics (NWBO) Earnings

  |   Expand Research on NWBO
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate N/A Revenue Growth Rate N/A
Average % Move 1-Wk after EPS N/A Normal Earnings Time Intra-Day
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/14/25 Q225 N/AN/A N/A N/AN/A N/A N/A N/A
11/21/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
8/26/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
8/19/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
8/16/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
5/27/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A
5/20/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A
5/16/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A